Active ingredient
Liraglutide
21 finished FDA listings contain Liraglutide as their only active ingredient; 1 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- LIRAGLUTIDE
- Dosage forms
- Injection, Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 13
- Strengths listed
- 18 mg/3ml · 6 mg/ml
- Brand names in FDA listings
- Saxenda, Victoza
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 475968
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 022341 | NOVO NORDISK INC | 2010-01-25 | 5 |
| NDA 206321 | NOVO | 2014-12-23 | 2 |
| ANDA 215503 | HIKMA | 2024-12-23 | 4 |
| ANDA 218115 | NANJING KING FRIEND | 2025-04-02 | 2 |
| ANDA 215421 | LUPIN | 2025-07-22 | 1 |
| ANDA 214568 | TEVA PHARMS | 2025-08-27 | 1 |
| ANDA 217590 | ORBICULAR | 2026-01-14 | 2 |
| ANDA 217234 | ORBICULAR | 2026-02-24 | 2 |
| ANDA 217063 | BIOCON PHARMA | 2026-02-24 | 1 |
| ANDA 215245 | BIOCON PHARMA | 2026-03-11 | 1 |
Official labeling on DailyMed
- LIRAGLUTIDE INJECTION [MEITHEAL PHARMACEUTICALS INC.] · version 9 · 2026-07-28
- LIRAGLUTIDE INJECTION, SOLUTION [CIPLA USA INC.] · version 6 · 2026-07-14
- LIRAGLUTIDE INJECTION [NORTHSTAR RX LLC] · version 4 · 2026-06-26
- SAXENDA (LIRAGLUTIDE) INJECTION, SOLUTION [NOVO NORDISK PHARMACEUTICAL INDUSTRIES, LP] · version 22 · 2026-06-15
- LIRAGLUTIDE INJECTION [HIKMA PHARMACEUTICALS USA INC.] · version 7 · 2026-06-11
- LIRAGLUTIDE INJECTION, SOLUTION [TEVA PHARMACEUTICALS, INC.] · version 4 · 2026-05-06
- LIRAGLUTIDE INJECTION [BIOCON PHARMA INC.] · version 12 · 2026-04-27
- LIRAGLUTIDE INJECTION, SOLUTION [ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED] · version 2 · 2026-04-17
- LIRAGLUTIDE INJECTION, SOLUTION [BIOCON PHARMA INC.] · version 8 · 2026-03-30
- LIRAGLUTIDE INJECTION, SOLUTION [ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED] · version 1 · 2026-03-16
- LIRAGLUTIDE INJECTION [TEVA PHARMACEUTICALS USA, INC.] · version 3 · 2026-03-02
- LIRAGLUTIDE INJECTION, SOLUTION [CIPLA USA INC.] · version 2 · 2026-01-23
Showing the 12 most recent of 21 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.